Related references
Note: Only part of the references are listed.Methicillin-resistant Staphylococcus pseudintermedius among dogs admitted to a small animal hospital
Ulrike Nienhoff et al.
VETERINARY MICROBIOLOGY (2011)
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid
Gary E. Stein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Linezolid therapy for pediatric thoracic spondylodiscitis due to Staphylococcus aureus sepsis
Andrzej Krzysztofiak et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Two dogs with iatrogenic discospondylitis caused by meticillin-resistant Staphylococcus aureus
M. Schwartz et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2009)
Infectious spondylodiscitis
Lucy Cottle et al.
JOURNAL OF INFECTION (2008)
Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis
Shafic Said Al-Nammari et al.
SPINE (2007)
Signalment and clinical features of diskospondylitis in dogs: 513 cases (1980-2001)
BA Burkert et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2005)
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme
CR Rayner et al.
CLINICAL PHARMACOKINETICS (2003)
Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog
JG Slatter et al.
XENOBIOTICA (2002)
Treatment options for vancomycin-resistant enterococcal infections
PK Linden
DRUGS (2002)
Radiographic findings during recovery from discospondylitis
MH Shamir et al.
VETERINARY RADIOLOGY & ULTRASOUND (2001)
Once-daily dosing in dogs optimizes daptomycin safety
FB Oleson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
